Urologic and reproductive health conditions
Urologic and reproductive health conditions is a research topic within Rheumatology. Science Explorer counts 26k research works in it since 1950. 9.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathology, diagnosis, and management of genitourinary soft tissue tumors and anomalies, including aggressive angiomyxoma, prostatic tumors, seminal vesicle cysts, fibroepithelial polyps, ejaculatory duct obstruction, and associated conditions like hemospermia and acrochordon. The papers cover a wide range of clinical, histopathological, and imaging aspects related to these genitourinary neoplasms.
- Angiomyxoma
- Prostate
- Seminal Vesicle
- Fibroepithelial Polyps
- Ejaculatory Duct Obstruction
- Mesenchymal Tumors
- Vulvovaginal Pathology
- Hemospermia
- Acrochordon
- Urethral Polyps
- Research works
- 26k fractional, since 1950
- In the world top 10%
- 2.6k per year above
- Top-10% rate
- 9.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Urologic and reproductive health conditions research?
By volume, the United States and India publish the most (611 and 387 works in 2022–2025).
By volume, 2022–2025
- 1 United States 611 works
- 2 India 387 works
- 3 China 367 works
- 4 Japan 150 works
- 5 United Kingdom 140 works
- 6 Italy 138 works
- 7 Germany 125 works
- 8 Türkiye 113 works
- 9 Spain 90 works
- 10 France 82 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Urologic and reproductive health conditions research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Urologic and reproductive health conditions research, followed by Mohammed V University and University College London.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 24 works
- 2 Mohammed V UniversityMorocco 13 works
- 3 University College LondonUnited Kingdom 11 works
- 4 Cleveland ClinicUnited States 11 works
- 5 Sichuan UniversityChina 11 works
- 6 Sağlık Bilimleri ÜniversitesiTürkiye 10 works
- 7 Post Graduate Institute of Medical Education and ResearchIndia 9 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 9 works
- 9 Institute of Medical SciencesIndia 9 works
- 10 The University of Texas Southwestern Medical CenterUnited States 8 works
Who are the leading researchers in Urologic and reproductive health conditions?
The most-cited researchers publishing on Urologic and reproductive health conditions include Peter R. Carroll.
- 1 Peter R. Carroll United States 2.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Urologic and reproductive health conditions research done?
The largest centres of Urologic and reproductive health conditions research in 2022–2025 are London (United Kingdom), New Delhi (India), Beijing (China) and Tokyo (Japan).
Where is the best place to study Urologic and reproductive health conditions?
Among universities, judged by research, University College London, All India Institute of Medical Sciences and Mohammed V University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University College LondonUnited Kingdom | 51.4 | 17.7% | 2.5× | 11 | +50.6% |
| 2 | All India Institute of Medical SciencesIndia | 50.6 | 3.3% | 11.9× | 24 | -17.6% |
| 3 | Mohammed V UniversityMorocco | 50.6 | 0.0% | 10.0× | 13 | +191.2% |
| 4 | Post Graduate Institute of Medical Education and ResearchIndia | 31.9 | 3.6% | 8.8× | 9 | +31.5% |
| 5 | Sichuan UniversityChina | 30.3 | 12.3% | 1.9× | 11 | +42.6% |
| 6 | Institute of Medical SciencesIndia | 28.6 | 0.4% | 8.5× | 9 | +71.9% |
| 7 | Sağlık Bilimleri ÜniversitesiTürkiye | 25.9 | 0.1% | 5.6× | 10 | — |
| 8 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 25.4 | 9.2% | 2.9× | 9 | +42.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Urologic and reproductive health conditions research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Urologic and reproductive health conditions.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.